Growth investors focus on stocks that are seeing above-average financial growth, as this feature helps these securities garner the market's attention and deliver solid returns. However, it isn't easy to find a great growth stock.That's because, these stocks usually carry above-average risk and volatility. In fact, betting on a stock for which the growth story is actually over or nearing its end could lead to significant loss.However, it's pretty easy to find cutting-edge growth stocks with the help of the Z ...

Investors interested in Medical - Products stocks are likely familiar with Phibro Animal Health (PAHC) and Stryker (SYK) . But which of these two stocks presents investors with the better value opportunity right now? Let's take a closer look.There are plenty of strategies for discovering value stocks, but we have found that pairing a strong Zacks Rank with an impressive grade in the Value category of our Style Scores system produces the best returns. The proven Zacks Rank emphasizes companies with positive ...

The proven Zacks Rank system focuses on earnings estimates and estimate revisions to find winning stocks. Nevertheless, we know that our readers all have their own perspectives, so we are always looking at the latest trends in value, growth, and momentum to find strong picks.Of these, perhaps no stock market trend is more popular than value investing, which is a strategy that has proven to be successful in all sorts of market environments. Value investors rely on traditional forms of analysis on key valuati ...

Phibro Animal Health Corporation’s (PAHC) focus on advancing vaccine technologies is poised to drive growth in the upcoming quarters. The company’s global growth prospects look encouraging. Yet, adverse currency fluctuations and fierce competitive impacts are concerns for Phibro’s operations.In the past year, this Zacks Rank #3 (Hold) company’s shares have rallied 82.8% compared with the industry’s 9.6% growth and the S&P 500 composite's 26.7% increase.The renowned animal health and mineral nutrition compan ...

Phibro Animal Health (PAHC) has seen impressive momentum in the past year, with its shares soaring 82.8%. It has significantly outperformed the 9.6% rise of the industry and the S&P 500 Composite’s 26.7% gain.Presently carrying a Zacks Rank #3 (Hold), the diversified animal health and mineral nutrition company is benefiting from the remarkable performance of the Animal Health business. Phibro is well-positioned to pursue global growth opportunities, while the resilience of the Mineral Nutrition arm is highl ...

Phibro Animal Health Corporation’s (PAHC) growth in the fiscal first quarter of 2025 is backed by sustained improvement in the Animal Health business. The company’s focus on advancing vaccine technologies instills optimism. A rebound of Mineral Nutrition and Performance Product businesses seems encouraging. Yet, adverse macroeconomic impacts are a concern for Phibro’s operations.In the past year, this Zacks Rank #2 (Buy) company’s shares have rallied 107.9% compared with the industry’s 20.9% growth and the ...

Growth stocks are attractive to many investors, as above-average financial growth helps these stocks easily grab the market's attention and produce exceptional returns. But finding a growth stock that can live up to its true potential can be a tough task.In addition to volatility, these stocks carry above-average risk by their very nature. Also, one could end up losing from a stock whose growth story is actually over or nearing its end.However, the Zacks Growth Style Score (part of the Zacks Style Scores sy ...

核心观点 - Zacks Premium 提供多种工具和服务，帮助投资者充分利用股市并增强投资信心，包括 Zacks Rank、Zacks Industry Rank、Zacks 1 Rank List、Equity Research 报告和 Premium 股票筛选工具 [1] - Zacks Style Scores 是与 Zacks Rank 并行的指标，帮助投资者选择在未来 30 天内超越市场的股票，基于价值、增长和动量特征，每只股票被分配 A 到 F 的评级，评级越高，股票超越市场的可能性越大 [3] - Phibro Animal Health Corporation (PAHC) 是一家领先的全球多元化动物健康和矿物营养公司，拥有 Zacks Rank 2 (Buy) 和 VGM Score of A，近期股价上涨 2.3%，分析师对 2025 财年的盈利预期上调，平均盈利惊喜率为 25.5% [13][14][15] Zacks Style Scores - **价值评分**：关注股票的估值比率，如市盈率 (P/E)、市盈率增长比 (PEG)、市销率 (Price/Sales)、市现率 (Price/Cash Flow) 等，以发现被低估的股票 [4] - **增长评分**：评估公司的财务实力和未来前景，考察历史和预测的盈利、销售和现金流，以识别可持续增长的股票 [5] - **动量评分**：利用股价和盈利预期的变化，帮助投资者在股票价格或盈利前景上升时买入高动量股票 [6] - **VGM 评分**：综合价值、增长和动量评分，帮助投资者找到在价值、增长和动量方面最具吸引力的股票 [7] Zacks Rank 与 Style Scores 的结合 - Zacks Rank 是一个利用盈利预期修正的专有股票评级模型，自 1988 年以来，Zacks Rank 1 (Strong Buy) 股票的平均年回报率为 25.41%，远超 S&P 500 [8][9] - Style Scores 与 Zacks Rank 结合使用，投资者应选择 Zacks Rank 1 或 2 且 Style Scores 为 A 或 B 的股票，以最大化成功概率 [10][11][12] 公司分析 - **Phibro Animal Health Corporation (PAHC)**：总部位于新泽西州，是全球领先的多元化动物健康和矿物营养公司，提供广泛的产品线，服务于食品动物市场，包括家禽、猪、牛和鱼类，同时涉足个人护理、汽车、工业化学和化学催化剂行业 [13] - **投资亮点**：PAHC 拥有 Zacks Rank 2 (Buy) 和 VGM Score of A，动量评分为 B，过去四周股价上涨 2.3%，2025 财年盈利预期上调，平均盈利惊喜率为 25.5% [14][15]

文章核心观点 - 文章推荐了Phibro Animal Health (PAHC)作为潜在的优质成长股，认为该公司具有良好的成长前景和强劲的财务表现 [2][10] 成长股的选择 - 成长股通常具有高于平均水平的财务增长，但也伴随着较高的风险和波动性 [1] - 使用Zacks Growth Style Score系统可以更有效地筛选出具有真实成长潜力的股票 [2] 公司财务表现 盈利增长 - 公司的历史EPS增长率为0.9%，但预计今年的EPS将增长30.7%，远超行业平均的20% [5] 资产利用率 - 公司的销售-总资产比率为1.07，意味着每美元资产产生1.07美元的销售，高于行业平均的0.61，显示出更高的资产利用效率 [6] 销售增长 - 公司今年的销售预计增长17.2%，而行业平均仅为0.7% [7] 盈利预测修订 - 公司当前年度的盈利预测在过去一个月内上调了4%，显示出市场对其未来表现的积极预期 [9] 综合评价 - 公司基于多项因素获得了B的成长评分，并且由于盈利预测的上调，持有Zacks Rank 1（强力买入）评级 [9][10] - 这种组合表明公司是潜在的市场表现优胜者，是成长投资者的理想选择 [10]

Have you been paying attention to shares of Phibro Animal Health (PAHC) ? Shares have been on the move with the stock up 5.2% over the past month. The stock hit a new 52-week high of $25.61 in the previous session. Phibro Animal Health has gained 120.6% since the start of the year compared to the 4.7% move for the Zacks Medical sector and the 15% return for the Zacks Medical - Products industry.What's Driving the Outperformance?The stock has a great record of positive earnings surprises, as it hasn't missed ...